Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs
NCT04662996Completed
- Sponsor
- University Hospital Tours
- Start
- Jun 2021
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by University Hospital Tours. Primary endpoints: miRNA profile and chemotherapy response at 30 months and miRNA profile and novel hormonal agent response at 30 months. Started Jun 2021; status: completed.
Beyond the preview
Go deeper on NCT04662996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04662996.